Brief: Edgewise Therapeutics On June 21 Notified Nasdaq Upon Director Resignation, Co Will No Longer Be In Compliance With Nasdaq Listing Rule 5605(C)(2)(A)
22/06/2023 11:27
June 22 (Reuters) - Edgewise Therapeutics Inc EWTX.O :
* EDGEWISE THERAPEUTICS-ON JUNE 21 NOTIFIED NASDAQ UPON
DIRECTOR
RESIGNATION CO WILL NO LONGER BE IN COMPLIANCE WITH NASDAQ
LISTING RULE 5605(C)(2)(A)
Source text for Eikon: [http://bitly.ws/JgfI]
Further company coverage: EWTX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Edgewise Therapeutics
See all newsBrief: Edgewise Therapeutics Doses First Patient In Phase 2 Equinox-Hfpef Trial Of Edg-15400
Edgewise Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Edgewise Therapeutics Q2 net loss widens on higher expenses
Brief: Edgewise Therapeutics Q2 Operating Income USD -61.943 Million
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending